Your browser doesn't support javascript.
loading
Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity.
Krassenburg, Lisette A P; Maan, Raoel; Ramji, Alnoor; Manns, Michael P; Cornberg, Markus; Wedemeyer, Heiner; de Knegt, Robert J; Hansen, Bettina E; Janssen, Harry L A; de Man, Robert A; Feld, Jordan J; van der Meer, Adriaan J.
Afiliação
  • Krassenburg LAP; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Canada.
  • Maan R; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Ramji A; Department of Medicine, Division of Gastroenterology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Manns MP; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Cornberg M; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Wedemeyer H; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; Department of Gastroenterology and Hepatology, Essen University Hospital, Essen, Germany.
  • de Knegt RJ; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Hansen BE; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Canada.
  • Janssen HLA; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Canada.
  • de Man RA; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Feld JJ; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Canada.
  • van der Meer AJ; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands. Electronic address: a.vandermeer@erasmusmc.nl.
J Hepatol ; 74(5): 1053-1063, 2021 05.
Article em En | MEDLINE | ID: mdl-33242501
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Carcinoma Hepatocelular / Hepatite C Crônica / Falência Renal Crônica / Cirrose Hepática / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Carcinoma Hepatocelular / Hepatite C Crônica / Falência Renal Crônica / Cirrose Hepática / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article